Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Chou, Stella T  [Clear All Filters]
2024
Gunawardena N, Chou ST. Generation of red blood cells from induced pluripotent stem cells. Curr Opin Hematol. 2024.
Pavani G, Klein JG, Nations CC, Sussman JH, Tan K, An HHyung, Abdulmalik O, Thom CS, Gearhart PA, Willett CMarie, et al. Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells. Blood Adv. 2024.
2023
Wilken MB, Maguire JAnn, Dungan LV, Gagne A, Osorio-Quintero C, Waxman EA, Chou ST, Gadue P, French DL, Thom CS. Generation of a human Tropomyosin 1 knockout iPSC line. Stem Cell Res. 2023;71:103161.
Breda L, Papp TE, Triebwasser MP, Yadegari A, Fedorky MT, Tanaka N, Abdulmalik O, Pavani G, Wang Y, Grupp SA, et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science. 2023;381(6656):436-443.
Sit YTing, Takasaki K, An HHyung, Xiao Y, Hurtz C, Gearhart P, Zhang Z, Gadue P, French D, Chou ST. Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis. JCI Insight. 2023.
Wilken MB, Fonar G, Nations C, Pavani G, Tsao V, Garifallou J, Tober J, Bennett L, Maguire JAnn, Gagne A, et al. Tropomyosin 1 deficiency facilitates cell state transitions to enhance hemogenic endothelial cell specification during hematopoiesis. bioRxiv. 2023.
2022
An HHyung, Gagne AL, Maguire JAnn, Pavani G, Abdulmalik O, Gadue P, French DL, Westhoff CMarie, Chou ST. The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine. Blood. 2022.
2019
M Murad H, Liem RI, Lang ES, Akl EA, Meerpohl JJ, DeBaun MR, Tisdale JF, Brandow AM, Lanzkron SM, Chou ST, et al. 2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations. Blood Adv. 2019;3(23):3945-3950.
2018
Gagne AL, Maguire JAnn, Gandre-Babbe S, Chou ST, Tasian SK, Loh ML, Weiss MJ, Gadue P, French DL. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res. 2018;31:157-160.
2015
Byrska-Bishop M, VanDorn D, Campbell AE, Betensky M, Arca PR, Yao Y, Gadue P, Costa FF, Nemiroff RL, Blobel GA, et al. Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus. J Clin Invest. 2015.
2013
Gandre-Babbe S, Paluru P, Aribeana C, Chou ST, Bresolin S, Lu L, Sullivan SK, Tasian SK, Weng J, Favre H, et al. Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia. Blood. 2013.